ACSS2 inhibitors AD-5584 and AD-8007 significantly reduce lipid storage and acetyl-CoA levels and block colony cell survival and induce cell death in breast cancer brain metastasis cells in vitro, as well as inhibit tumor growth and survival in the brain microenvironment without causing overt toxicity to normal brain tissue [36]. Here, ACSS2 is linked to neoplasm.